Neuronetics, Inc. financial data

Symbol
STIM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3222 Phoenixville Pike, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 379 % -9.33%
Quick Ratio 32.2 % -30.9%
Debt-to-equity 331 % +178%
Return On Equity -161 % -129%
Return On Assets -37.3 % -16.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.3M shares +4.89%
Common Stock, Shares, Outstanding 30.3M shares +4.9%
Entity Public Float 56.5M USD -16.5%
Common Stock, Value, Issued 303K USD +4.84%
Weighted Average Number of Shares Outstanding, Basic 30.3M shares +4.82%
Weighted Average Number of Shares Outstanding, Diluted 30.3M shares +4.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 72.7M USD +5.03%
Research and Development Expense 9.21M USD -11.9%
Selling and Marketing Expense 47.5M USD -0.15%
General and Administrative Expense 25.8M USD +1.09%
Operating Income (Loss) -27.5M USD +18.7%
Net Income (Loss) Attributable to Parent -36.4M USD -10%
Earnings Per Share, Basic -1.21 USD/shares -2.54%
Earnings Per Share, Diluted -1.21 USD/shares -2.54%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.9M USD -41.8%
Accounts Receivable, after Allowance for Credit Loss, Current 16.8M USD +12%
Inventory, Net 4.96M USD -49.1%
Assets, Current 53.5M USD -24.7%
Property, Plant and Equipment, Net 1.64M USD -20.7%
Operating Lease, Right-of-Use Asset 2.33M USD -20.2%
Other Assets, Noncurrent 4.94M USD +20.9%
Assets 74.1M USD -20.3%
Accounts Payable, Current 3.3M USD +16.8%
Accrued Liabilities, Current 11.4M USD +13.9%
Liabilities, Current 16.9M USD +10.2%
Operating Lease, Liability, Noncurrent 1.83M USD -26.9%
Liabilities 64.7M USD +17.6%
Retained Earnings (Accumulated Deficit) -407M USD -9.83%
Stockholders' Equity Attributable to Parent 9.38M USD -75.3%
Liabilities and Equity 74.1M USD -20.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12M USD +21%
Net Cash Provided by (Used in) Financing Activities 499K USD
Net Cash Provided by (Used in) Investing Activities 68K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 30.3M shares +4.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.9M USD -41.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.67M USD +56.6%
Deferred Tax Assets, Valuation Allowance 94.5M USD +8.92%
Deferred Tax Assets, Gross 98.9M USD +8.89%
Operating Lease, Liability 2.7M USD -19.5%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD -22.2%
Property, Plant and Equipment, Gross 5M USD -11%
Operating Lease, Liability, Current 862K USD +2.62%
Lessee, Operating Lease, Liability, to be Paid, Year Two 921K USD +2.56%
Lessee, Operating Lease, Liability, to be Paid, Year One 898K USD +2.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 343K USD -38.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 882K USD -4.24%
Deferred Tax Assets, Operating Loss Carryforwards 82.2M USD +8.11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 116K USD -86.8%
Operating Lease, Payments 275K USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 560K USD +8.53%
Deferred Tax Assets, Net of Valuation Allowance 4.38M USD +8.06%
Share-based Payment Arrangement, Expense 5.95M USD -23.8%
Interest Expense 7.37M USD +53.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%